Dual-targeting biomimetic liposome with elemene (ele) and cabazitaxel (ctx), and preparation method and use thereof
US-2024252436-A1 · Aug 1, 2024 · US
US9718921B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9718921-B2 |
| Application number | US-201414770417-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 26, 2014 |
| Priority date | Feb 26, 2013 |
| Publication date | Aug 1, 2017 |
| Grant date | Aug 1, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for preparation of novel amphiphilic derivatives of thioether containing block copolypeptides with narrow chain length distributions are described. These block copolymers can be chemically modified by oxidation and alkylation of the thioether containing residues. These materials generate self-assembled micelles, vesicles and hydrogels, or emulsions with oil phases. These assemblies can be used to encapsulate and delivery therapeutic molecules. The assemblies can be taken up by cells to release molecules from the assemblies.
Opening claim text (preview).
What is claimed is: 1. A process for preparing an amphiphilic block copolypeptide with oxidized thioether groups comprising: synthesizing a block copolypeptide wherein at least one of the blocks contains at least 3 consecutive hydrophobic amino acids selected from leucine, phenylalanine, alanine, isoleucine, valine, tyrosine, and tryptophan, and wherein at least one of the blocks contains at least 3 consecutive thioether containing amino acids selected from methionine, S-methyl-cysteine, S-ethyl-cysteine, S-allyl-cysteine, S-benzyl-cysteine, S-farnesyl-cysteine, S-propargyl-cysteine, S-methyl-homocysteine, S-ethyl-homocysteine, S-allyl-homocysteine, S-benzyl-homocysteine, S-farnesyl-homocysteine, and S-propargyl-homocysteine; adding an oxidizing reagent to the block copolypeptide; and reacting the block copolypeptide so that the majority of the thioether groups in the polypeptide are oxidized, thereby forming the amphiphilic block copolypeptide with oxidized thioether groups. 2. The process of claim 1 , wherein the thioether containing amino acids are methionine. 3. The process of claim 1 , wherein the thioether containing amino acids are one or more of S-methyl-cysteine, S-ethyl-cysteine, S-allyl-cysteine, S-benzyl-cysteine, S-farnesyl-cysteine, and S-propargyl-cysteine. 4. The process of claim 1 , wherein the thioether containing amino acids are one or more of the following: S-methyl-homocysteine, S-ethyl-homocysteine, S-allyl-homocysteine, S-benzyl-homocysteine, S-farnesyl-homocysteine, and S-propargyl-homocysteine. 5. The process of claim 1 , wherein the oxidized thioether groups in the amphiphilic block copolypeptide are one or more of the following: sulfoxide, and sulfone. 6. The process of claim 1 wherein the hydrophobic amino acids are one or more of L-leucine, L-phenylalanine, L-alanine, L-isoleucine, L-valine, L-tyrosine, and L-tryptophan. 7. The process of claim 1 , wherein the block copolypeptide is a diblock copolypeptide. 8. The process of claim 1 , wherein the block copolypeptide is a triblock copolypeptide. 9. The process of claim 1 , wherein the thioether containing amino acids are L-methionine. 10. The process of claim 1 , wherein the hydrophobic amino acids are L-leucine or L-phenylalanine. 11. The process of claim 1 , wherein the oxidizing reagent comprises H 2 O 2 . 12. The process of claim 1 , wherein the amphiphilic block copolypeptide with oxidized thioether groups is poly(L-methionine-sulfoxide) 65 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 ; poly(Nε-trifluoroacetyl-L-lysine) 11 -block-poly(L-methionine sulfoxide) 55 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 ; poly(Nε-trifluoroacetyl-L-lysine) 21 -block-poly(L-methionine sulfoxide) 55 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 ; poly(L-lysine) 10 -block-poly(L-methionine sulfoxide) 55 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 ; poly(L-lysine) 20 -block-poly(L-methionine sulfoxide) 55 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 ; poly(L-homoarginine) 10 -block-poly(L-methionine sulfoxide) 55 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 ; or poly(L-homoarginine) 20 -block-poly(L-methionine sulfoxide) 55 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 .
Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34) · CPC title
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence) · CPC title
Polymers modified by chemical after-treatment · CPC title
Alpha-amino-carboxylic acids {(polysuccinimides C08G73/1092)} · CPC title
Polyamides containing atoms other than carbon, hydrogen, oxygen, and nitrogen (C08G69/12, C08G69/32 take precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.